0001193125-23-215092.txt : 20230817 0001193125-23-215092.hdr.sgml : 20230817 20230817163226 ACCESSION NUMBER: 0001193125-23-215092 CONFORMED SUBMISSION TYPE: F-X PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230817 DATE AS OF CHANGE: 20230817 EFFECTIVENESS DATE: 20230817 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Cresco Labs Inc. CENTRAL INDEX KEY: 0001832928 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 981505364 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: F-X SEC ACT: 1933 Act SEC FILE NUMBER: 333-274047 FILM NUMBER: 231182366 BUSINESS ADDRESS: STREET 1: 400 W ERIE ST SUITE 110 CITY: CHICAGO STATE: IL ZIP: 60654 BUSINESS PHONE: (312) 929-0993 MAIL ADDRESS: STREET 1: 400 W ERIE ST SUITE 110 CITY: CHICAGO STATE: IL ZIP: 60654 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Cresco Labs Inc. CENTRAL INDEX KEY: 0001832928 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 981505364 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: F-X BUSINESS ADDRESS: STREET 1: 400 W ERIE ST SUITE 110 CITY: CHICAGO STATE: IL ZIP: 60654 BUSINESS PHONE: (312) 929-0993 MAIL ADDRESS: STREET 1: 400 W ERIE ST SUITE 110 CITY: CHICAGO STATE: IL ZIP: 60654 F-X 1 d611865dfx.htm F-X F-X

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM F-X

 

 

APPOINTMENT OF AGENT FOR SERVICE

OF PROCESS AND UNDERTAKING

 

 

 

A.    Name of issuer or person filing (“Filer”):                 Cresco Labs Inc.
B.   

(1)   This is [check one]

  

☒   an original filing for the Filer

  

☐   an amended filing for the Filer

  

(2)   Check the following box if you are filing the Form F-X in paper in accordance with Regulation S-T Rule 101(b)(9)  ☐

C.    Identify the filing in conjunction with which this form is being filed:
   Name of Registrant:    Cresco Labs Inc.
   Form type:    Registration Statement on Form F-10
   File Number (if known):    333-274047
   Filed by:    Cresco Labs Inc.
   Date Filed (if filed concurrently, so indicate):    August 17, 2023 (filed concurrently)
D.    The Filer is incorporated or organized under the laws of the Province of British Columbia, Canada and has its principal place of business at 400 W Erie St #110, Chicago, IL 60654 and telephone number (312) 929-0993.
E.   

The Filer designates and appoints Cresco Labs, LLC, an Illinois limited liability company (“Agent”), located at 400 W Erie St #110, Chicago, IL 60654; telephone (312) 929-0993 as the agent of the Filer upon whom may be served any process, pleadings, subpoenas, or other papers in:

 

(a) any investigation or administrative proceeding conducted by the Securities and Exchange Commission (the “Commission”); and

 

(b) any civil suit or action brought against the Filer or to which the Filer has been joined as defendant or respondent, in any appropriate court in any place subject to the jurisdiction of any state or of the United States or of any of its territories or possessions or of the District of Columbia, where the investigation, proceeding or cause of action arises out of or relates to or concerns any offering made or purported to be made in connection with the securities registered or qualified by the Filer on Form F-10 on the date hereof or any purchases or sales of any security in connection therewith. The Filer stipulates and agrees that any such civil suit or action or administrative proceeding may be commenced by the service of process upon, and that service of an administrative subpoena shall be effected by service upon such agent for service of process, and that service as aforesaid shall be taken and held in all courts and administrative tribunals to be valid and binding as if personal service thereof had been made.

F.   

The Filer stipulates and agrees to appoint a successor agent for service of process and file an amended Form F-X if the Filer discharges the Agent or the Agent is unwilling or unable to accept service on behalf of the Filer at any time until six years have elapsed from the date the Filer has ceased reporting under the Exchange Act.

 

The Filer further undertakes to advise the Commission promptly of any change to the Agent’s name or address during the applicable period by amendment of this Form, referencing the file number of the relevant form in conjunction with which the amendment is being filed.

G.    The Filer undertakes to make available, in person or by telephone, representatives to respond to inquiries made by the Commission staff, and to furnish promptly, when requested to do so by the Commission staff, information relating to the Form F-10, the securities to which the Form F-10 relates, and the transaction in such securities.

 

 

 

The Filer certifies that it has duly caused this power of attorney, consent, stipulation and agreement to be signed on its behalf by the undersigned, thereto duly authorized, in Chicago, Illinois this 17th day of August, 2023.

 

CRESCO LABS INC.
By:   /s/ Charles Bachtell
  Name:   Charles Bachtell
  Title:   Chief Executive Officer

This statement has been signed by the following person in the capacity and on the date indicated:

 

CRESCO LABS, LLC

(Agent for Service)

By:   /s/ John Schetz
  Name:   John Schetz
  Title:   General Counsel

Dated: August 17, 2023